Vaccine supply chain upgraded to cope with demand

Source: Transport & Logistics News, 14 May 2009

GlaxoSmithKline Australia (GSKA) has developed and implemented a new vaccine distribution concept for cold chain sensitive products.

The company spent 12 months designing, trialling and implementing this new delivery system to ensure vaccine cold chain integrity for patients while managing diverse delivery destinations and combinations.

Click here to read more